CHRS
Coherus Oncology, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.42
+3.65%Leverage
- Debt / equity
- 0.62x
- Net debt / equity
- -0.74x
- Debt / assets
- 0.20x
- Debt / EBITDA
- -0.25x
- Net debt / EBITDA
- 0.30x
Liquidity & coverage
- Current ratio
- 1.77x
- Quick ratio
- 1.70x
- Cash ratio
- 1.39x
- Interest coverage
- -17.24x
- EBITDA / interest
- -16.34x
- Working capital
- $58.3M
Cash & dividend
- FCF / debt
- -6.47x
- Cash flow / debt
- -6.47x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026